Latest news
FDA Approves Labcorp's PGDx Elio Tissue Complete CDx for Advanced Melanoma - Dermatology TimesDermatology Times · Mon, 10 Aug 2026 15:10:24 GMTLabcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma - PR NewswirePR Newswire · Mon, 10 Aug 2026 11:00:00 GMTFor advanced melanoma, Labcorp's test supports access to targeted therapies - Stock TitanStock Titan · Mon, 10 Aug 2026 11:00:00 GMTLabcorp Holdings Inc. (LH) stock price, news, quote and history - Yahoo Finance AustraliaYahoo Finance Australia · Sat, 08 Aug 2026 15:37:25 GMTLabcorp Launches FDA-Approved IHC Companion Diagnostic for Prostate Cancer - Clinical Lab ProductsClinical Lab Products · Wed, 05 Aug 2026 20:52:25 GMTLabcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer - MorningstarMorningstar · Tue, 04 Aug 2026 16:00:00 GMTLabcorp Test May Identify Prostate Cancer Patients for TRUQAP - Stock TitanStock Titan · Tue, 04 Aug 2026 11:00:00 GMTLabcorp launches FDA-approved test to identify prostate cancer patients for TRUQAP® treatment. - PluangPluang · Tue, 04 Aug 2026 07:00:00 GMT